< Back to previous page

Publication

Global perspectives on immunization against SARS-CoV-2 during pregnancy and priorities for future research

Journal Contribution - e-publication

Subtitle:an international consensus paper from the World Association of Infectious Diseases and Immunological Disorders
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.
Journal: Frontiers in immunology
ISSN: 1664-3224
Volume: 12
Publication year:2021
Keywords:A1 Journal article
Accessibility:Open